2.98USD
−31.84 MUSD
48.82 MUSD
6.15 M
About MEI Pharma, Inc.
Sector
CEO
David M. Urso
Headquarters
San Diego
Website
Employees (FY)
46
Founded
2000
ISIN
US55279B3015
FIGI
BBG000BSGT68
MEI Pharma, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. Its programs include Voruciclib and ME-344. The company was founded on December 1, 2000, and is headquartered in San Diego, CA.
MEIP LongAnalysis of the MEIP instrument and the possibility of its future movement relative to price ranges.
MEIP BullishThe most recent candle closed above the .5 fib level and the MACD just crossed to the bullish side.
Friday's candle also tested the descending trend line. Looking for a close above the upper trend line to open a swing position.
Targeting: $3.19, $3.37, $3.52 in the short term.
Choppy chop chop down?Choppy price action. Broke out from the descending triangle but little volume thus the retracement back to the key s/r neckline. Three-point of confirmation above 4H support could be broken if volume does not pick up.
Not financial advice
MEIP Break OutMACD is curling up for a cross and the 9ema is crossing the 20ema. Last candle showed strength and closed just bellow the 50% fibonacci level which is resistance. Looking for a break of $3.90
Short term target $4.58
MEIP - Wedge BreakoutMEI Pharma
Possible wedge breakout
MEI Pharma is a pharmaceutical company, which engages in the clinical development of therapies for cancer. Its drug candidates include Pracinostat, an oral HDAC inhibitor that is being developed in combination with azacitidine for the treatment of acute myeloid le
Both its technical analysis and fundamental reports look great. Both its technical analysis and fundamental reports look great. This is a perfect time to buy this stock.
MEIP Possible Bull RunRecent price action formed a Daily Pin Bar off historical horizontal support and trend line. There is also Bullish Divergence with respect price and STOCHRSI. The 50% FIB ($2.60) just above current price demonstrated it is respected as price sat on it for a bit. The confluence of horizontal and tren
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MEIP is 3.25 USD — it has decreased by 0.61% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange MEI Pharma, Inc. stocks are traded under the ticker MEIP.
MEI Pharma, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for MEI Pharma, Inc. has a max estimate of 42.00 USD and a min estimate of 7.00 USD.
MEIP earnings for the last quarter are 8.46 USD whereas the estimation was −1.80 USD which accounts for 571.31% surprise. Estimated earnings for the next quarter are −1.41 USD. See more details about MEI Pharma, Inc. earnings.
MEI Pharma, Inc. revenue for the last quarter amounts to 65.30 M USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach 100.00 K USD.
Yes, you can track MEI Pharma, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, MEIP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEI Pharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 46.00 employees. See our rating of the largest employees — is MEI Pharma, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEI Pharma, Inc. EBITDA is 17.35 M USD, and current EBITDA margin is −64.22%. See more stats in MEI Pharma, Inc. financial statements.